lomustine has been researched along with improsan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Douglass, HO; Engstrom, PF; Kaufman, J; Klaassen, D; MacIntyre, JM; Von Hoff, D | 1 |
1 trial(s) available for lomustine and improsan
| Article | Year |
|---|---|
Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Colonic Neoplasms; Drug Evaluation; Humans; Lomustine; Mesylates; Piperazines; Random Allocation; Razoxane; Rectal Neoplasms | 1985 |
1 other study(ies) available for lomustine and improsan
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |